ARCHIVES

Drugs and Targets: Blincyto granted accelerated approval in R/R ALL

This article is from The Cancer Letter archive.

Vol. 40 No. 45 | December 5, 2014

Download PDF Visit The Full Archive

Related Articles

IVAX And It’s Portfolio

December 22, 1994

NIH Tells Grant Applicants One Resubmission Is Enough.

October 24, 2008

Cancer Documentary Provides Argument for Increased Funding

May 23, 1986

Guest Editorial by Robert Cook-Deegan: Myriad Case Ruling Likely to Concur With DOJ Arguments

April 19, 2013

Cancer Congress Scientific Program To Update Basic, Clinical Science

April 2, 1982

Hurricane Katrina: Cancer groups, NCI offer help to displaced patients and caregivers.

September 9, 2005